An official website of the United States government
This repository is under review for potential modification in compliance with Administration directives.
Title | PMID | PMCID | Public Release Type | Publication Year | DOI | Study Acronym | Study Network | Request ID(s) | Public Release Origin |
|---|---|---|---|---|---|---|---|---|---|
| Among Patients with Nonalcoholic Fatty Liver Disease, Modest Alcohol Use is Associated with Less Improvement in Histologic Steatosis and Steatohepatitis | 29378307 | PMC6098737 | Journal | 2018 | 10.1016/j.cgh.2018.01.026 | FLINT | Nonalcoholic Steatohepatitis Clinical Research Network (NASH) | 21513, 21515 | Secondary Research |
| Association of changes in histological severity of non-alcoholic steatohepatitis and changes in patient-reported quality of life | 35903833 | PMC9512481 | Journal | 2022 | 10.1002/hep4.2044 | PIVENS, FLINT | Nonalcoholic Steatohepatitis Clinical Research Network (NASH) | 23138 | Secondary Research |
| Changes in abdominal adipose tissue depots assessed by MRI correlate with hepatic histologic improvement in non-alcoholic steatohepatitis. | 36368598 | PMC9852022 | Journal | 2023 | 10.1016/j.jhep.2022.10.027 | FLINT | Nonalcoholic Steatohepatitis Clinical Research Network (NASH) | 21852 | Secondary Research |
| Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial. | 25468160 | PMC4447192 | Journal | 2015 | 10.1016/S0140-6736(14)61933-4 | FLINT | Nonalcoholic Steatohepatitis Clinical Research Network (NASH) | Contributing Study | |
| Hepatic R2* is more strongly associated with proton density fat fraction than histologic liver iron scores in patients with nonalcoholic fatty liver disease | 30318834 | PMC6449180 | Journal | 2019 | 10.1002/jmri.26312 | FLINT | Nonalcoholic Steatohepatitis Clinical Research Network (NASH) | 21852 | Secondary Research |
| Improvements in Histologic Features and Diagnosis Associated With Improvement in Fibrosis in Nonalcoholic Steatohepatitis: Results From the Nonalcoholic Steatohepatitis Clinical Research Network Treatment Trials. | 30549292 | PMC6570584 | Journal | 2019 | 10.1002/hep.30418 | FLINT | Nonalcoholic Steatohepatitis Clinical Research Network (NASH) | 21513 | Secondary Research |
| Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease | 34670043 | PMC8881985 | Journal | 2022 | 10.1056/NEJMoa2029349 | FLINT | Nonalcoholic Steatohepatitis Clinical Research Network (NASH) | 21167, 21177, 21318, 21513, 21515, 21668, 21721, 22585, 22613, 22939, 22935, 22936, 22937, 22938, 23122 | Secondary Research |
| Testosterone is Associated With Nonalcoholic Steatohepatitis (NASH) and Fibrosis in Pre-Menopausal Women With NAFLD | 33010412 | PMC8175071 | Journal | 2020 | 10.1016/j.cgh.2020.09.045 | FLINT | Nonalcoholic Steatohepatitis Clinical Research Network (NASH) | 21167, 21177, 21318, 21513, 21515, 21668, 21721, 22585, 22613 | Secondary Research |
| The Nimble Stage 1 Study Validates Diagnostic Circulating Biomarkers for Nonalcoholic Steatohepatitis | 36711803 | PMC9882658 | Journal | 2023 | 10.21203/rs.3.rs-2492725/v1 | FLINT | Nonalcoholic Steatohepatitis Clinical Research Network (NASH) | 21167, 21177, 21318, 21668, 21721, 22939, 22935, 22936, 22937, 22938, 23122, 23382 | Secondary Research |
| The roles of type 2 diabetes and obesity in disease activity and progression of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis | 37933187 | Journal | 2024 | 10.1080/03007995.2023.2279676 | FLINT, CyNCh, NAFLD Adult, NAFLD Pediatric, PIVENS, TONIC | Nonalcoholic Steatohepatitis Clinical Research Network (NASH) | 23059 | Secondary Research |
- Previous
- 1(current)
- Next